Lifeward Stock (NASDAQ:LFWD)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$6.98

52W Range

$4.14 - $14.88

50D Avg

$6.96

200D Avg

$7.28

Market Cap

$11.39M

Avg Vol (3M)

$10.55K

Beta

0.37

Div Yield

-

LFWD Company Profile


Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

80

IPO Date

Sep 12, 2014

Website

LFWD Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24
Product$17.16M$19.92M

Fiscal year ends in Dec 25 | Currency in USD

LFWD Financial Summary


Dec 25Dec 24Dec 23
Revenue$22.03M$25.66M$13.85M
Operating Income$-16.89M$-19.55M$-23.61M
Net Income$-19.91M$-28.94M$-22.13M
EBITDA$-16.89M$-24.93M$-21.77M
Basic EPS$-17.16$-39.96$-31.08
Diluted EPS$-17.16$-39.96$-31.08

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 15, 26 | 12:00 AM
Q3 25Nov 14, 25 | 8:30 AM
Q2 25Aug 14, 25 | 8:30 AM

Peer Comparison


TickerCompany
SINTSintx Technologies, Inc.
PTHLPheton Holdings Ltd Class A Ordinary Shares
SBFMSunshine Biopharma, Inc.
RNAZTransCode Therapeutics, Inc.
INABIN8bio, Inc.
LYRALyra Therapeutics, Inc.
TNONTenon Medical, Inc.
XAIRBeyond Air, Inc.
IINNInspira Technologies Oxy B.H.N. Ltd.
DHAIDIH Holding US, Inc.